CAP
BCAB icon

Columbia Advisory Partners’s BioAtla BCAB Stock Holding History

Columbia Advisory Partners’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-521
Closed -$14.8K – 96
2025
Q4 		$14.8K Hold
521
– – 0.01% 90
2025
Q3 		$17.9K Hold
521
– – 0.01% 89
2025
Q2 		$10.3K Hold
521
– – 0.01% 79
2025
Q1 		$9.04K Hold
521
– – 0.01% 71
2024
Q4 		$15.4K Buy
521
+302
+138% +$25.3K 0.01% 63
2024
Q3 		$19.3K Buy
+219
New +$18.4K 0.02% 58

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Columbia Advisory Partners's BCAB Position: Q1 2026 in Review

Columbia Advisory Partners sold out of BioAtla (BCAB) in Q1 2026, closing a stake of 521 shares — an estimated $14.8K sold.

Columbia Advisory Partners first reported a position in BCAB in Q3 2024 and held it in 6 quarters. The position peaked at $19.3K in Q3 2024. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • Columbia Advisory Partners reported no remaining BioAtla position as of Q1 2026 after selling out during the quarter.
  • Columbia Advisory Partners sold 521 BioAtla shares in Q1 2026, an estimated $14.8K.
  • Columbia Advisory Partners first reported a position in BioAtla in Q3 2024 and held it in 6 quarters.
  • Columbia Advisory Partners's BioAtla position peaked at $19.3K in Q3 2024.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Columbia Advisory Partners's 13F filing for Q1 2026, filed 23 Apr 2026.